Group B Streptococcus (GBS) Associated Stillbirths in a High Burden Setting
NCT ID: NCT02339077
Last Updated: 2024-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
354 participants
OBSERVATIONAL
2014-10-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Group B Streptococcus (GBS) Infection and in Preterm Labor Women Conceived Through IVF
NCT03122704
Zambian Preterm Birth Prevention Study
NCT02738892
Cardiovascular Risk in Infants Exposed to Pre-eclampsia in Utero
NCT05091827
Antenatal Detection of Fetal Growth Restriction and Stillbirths Rate.
NCT01995968
Clinical Study of Pregnant Women With COVID-19
NCT04701944
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants aged ≥18 years
* Able to understand and comply with planned study procedures
* Provides written informed consent (either generic ICF or V98\_28OBTP)
Exclusion Criteria
1 Day
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Witwatersrand, South Africa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Farzanah Laher
Dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Respiratory and Meningeal Pathogen Research Unit
Johannesburg, Gauteng, South Africa
Chris Hani Baragwanath Academic Hospital
Johannesburg, Gauteng, South Africa
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
V98_27OBTP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.